This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

King's College London develops ERB antibiotics

Analysis based on 7 articles · First reported May 29, 2026 · Last updated May 29, 2026

Sentiment
70
Attention
6
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This breakthrough could significantly impact pharmaceutical companies involved in antibiotic development, potentially leading to new drug pipelines and revitalizing existing ones. It offers hope for combating the growing global threat of antibiotic resistance, which could reduce healthcare costs and improve public health outcomes, positively affecting the healthcare sector.

Pharmaceuticals Biotechnology Healthcare

Researchers at King s College London, led by Professor Khondaker Miraz Rahman and in collaboration with Professor Mark Sutton from the United Kingdom — UK Health Security Agency, have developed a new approach called 'Efflux Resistance Breaker' (ERB) for designing antibiotics. This method chemically redesigns antibiotics to prevent bacteria from pumping them out of cells, thereby restoring their effectiveness against drug-resistant infections. The study, published in the Journal of Medicinal Chemistry, provides a proof of concept for building resistance-breaking properties directly into antibiotic molecules. This innovation aims to discover new treatments and revive existing antibiotics that have lost efficacy due to bacterial evolution, addressing the critical global threat of antimicrobial resistance highlighted by the World Health Organization.

per
Khondaker Miraz Rahman, a Professor at King s College London, led the study, gaining recognition for his work in medicinal chemistry and antibiotic development.
Importance 80.0 Sentiment 70.0
per
Mark Sutton from the United Kingdom — UK Health Security Agency collaborated on the project, contributing expertise on efflux pumps and antibiotic resistance.
Importance 70.0 Sentiment 60.0
govactor
The United Kingdom — UK Health Security Agency collaborated on the study, supporting research into overcoming antibiotic resistance, which aligns with its public health mission.
Importance 70.0 Sentiment 60.0
ngo
The World Health Organization is mentioned as a source for statistics on antibiotic resistance, highlighting the global importance of the research.
Importance 20.0 Sentiment 0.0
oth
The Journal of Medicinal Chemistry published the study, serving as the platform for disseminating this scientific breakthrough.
Importance 10.0 Sentiment 10.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.